drugset

drugset / Trial / NCT03493165

Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

NCT03493165 ↗

Expanded access No longer available The University of Texas Health Science Center at San Antonio

Summary

Single patient treatment with everolimus.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Everolimus	Small molecule	—	—

Indications